Riboflavin-containing telodendrimer nanocarriers for efficient doxorubicin delivery: High loading capacity, increased stability, and improved anticancer efficacy
Open Access
- 1 October 2017
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 141, 161-175
Abstract
No abstract availableKeywords
Funding Information
- NIH/NCI (R01CA140449)
- NIH/NIBIB (1R21EB019607)
- Napi Family Research
- New York State Department of Health (DOH01-Rowley-2015-00067)
This publication has 70 references indexed in Scilit:
- Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian CancerJournal of Drug Delivery, 2013
- Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel deliveryBiomaterials, 2011
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumorsProceedings of the National Academy of Sciences, 2011
- Doxorubicin as a Molecular Nanotheranostic Agent: Effect of Doxorubicin Encapsulation in Micelles or Nanoemulsions on the Ultrasound-Mediated Intracellular Delivery and Nuclear TraffickingMolecular Pharmaceutics, 2010
- Well-Defined, Size-Tunable, Multifunctional Micelles for Efficient Paclitaxel Delivery for Cancer TreatmentBioconjugate Chemistry, 2010
- Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugsBiomaterials, 2010
- Exceptionally High Payload of Doxorubicin in Hollow Gold Nanospheres for Near-Infrared Light-Triggered Drug ReleaseACS Nano, 2010
- A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxelJournal of Controlled Release, 2008
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002